Dermatology startup Cureskin announced raising $20 million (over Rs 165 crore) in a funding round led by Healthquad, a digital health-focused venture capital fund. The startup disclosed that its existing investors JSW Ventures, Khosla Ventures, and Sharrp Ventures also participated in the Series B funding round.
This latest investment increases Cureskin’s total funding to $26 million, furthering its goal of expanding access to quality dermatological care across the country. In 2022, JSW Ventures had invested $5 million in the startup.
Through its mobile app, Cureskin has treated over 15 lakh customers, with 80 per cent of them hailing from small towns. Guna Kakulapati, co-founder and CEO of the startup, highlighted that various conditions like acne, hyper-pigmentation, post-acne issues, and hair loss have been addressed.
Cureskin operates as an AI-driven dermatology platform, offering clinically validated solutions for skin and hair health.
Healthquad functions as a venture capital fund specializing in digital health, whereas JSW Ventures serves as an early-stage institutional venture capital fund supported by the family office of the JSW Group.
Guna Kakulapati, CEO and Co-founder of Cureskin said, “These funds will help further enhance our AI capabilities, accelerate our growth and expand solution offerings. We aim to provide optimal skin and hair health to millions of individuals across the country.”
